EP0706399A1 - Compositions and process for removing bile salts - Google Patents

Compositions and process for removing bile salts

Info

Publication number
EP0706399A1
EP0706399A1 EP94919283A EP94919283A EP0706399A1 EP 0706399 A1 EP0706399 A1 EP 0706399A1 EP 94919283 A EP94919283 A EP 94919283A EP 94919283 A EP94919283 A EP 94919283A EP 0706399 A1 EP0706399 A1 EP 0706399A1
Authority
EP
European Patent Office
Prior art keywords
monomer
polymer
styrene
polymer further
fluorinated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94919283A
Other languages
German (de)
French (fr)
Other versions
EP0706399A4 (en
Inventor
W. Harry Mandeville, Iii
Stephen Randall Holmes-Farley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Geltex Pharmaceuticals Inc
Original Assignee
Geltex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geltex Pharmaceuticals Inc filed Critical Geltex Pharmaceuticals Inc
Publication of EP0706399A1 publication Critical patent/EP0706399A1/en
Publication of EP0706399A4 publication Critical patent/EP0706399A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/10Esters
    • C08F220/34Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • A61K31/787Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/795Polymers containing sulfur
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/52Amides or imides
    • C08F220/54Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide
    • C08F220/60Amides, e.g. N,N-dimethylacrylamide or N-isopropylacrylamide containing nitrogen in addition to the carbonamido nitrogen
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00Chemical modification by after-treatment

Definitions

  • This invention relates to removing bile salts from a patient.
  • Sequestering and removing bile salts in a patient can be used to reduce the patient's cholesterol level.
  • Ion exchange resins which, when ingested, remove bile salts via the digestive tract, have been used for this purpose. Removal of bile salts will cause the body to prepare more bile salts. Because the biological precursor to bile salt is cholesterol, the metabolism of cholesterol to make bile salts is accompanied by a simultaneous reduction in the cholesterol in the patient.
  • the invention features a method of removing bile salts from a patient by ion exchange that includes administering to the patient a therapeutically effective amount of one or more highly crosslinked polymers that are non-toxic and stable once ingested.
  • the polymers are characterized by a repeat unit having the formula
  • n is an integer
  • R 1 is H or a c i"" 8 all ⁇ yl group (which may be straight chain or branched. O substituted or unsubstituted, e.g., methyl)
  • M is -C-Z-R 2 or -Z-R 2
  • Z is O, NR 3 , S, or (CH 2 ) m
  • m 0-10
  • R 3 is H or a C J -C 8 alkyl group (which may be straight chain or branched, substituted or unsubstituted, e.g., methyl); and
  • R 2 is
  • each R 4 , R 5 , and R 6 independently, is H, a CJL-C Q alkyl group (which may be straight chain or branched, substituted or unsubstituted, e.g. , methyl) , or an aryl group (e.g., having one or more rings and which may be substituted or unsubstituted, e.g., phenyl, naphthyl, imidazolyl, or pyridyl) .
  • non-toxic it is meant that when ingested in therapeutically effective amounts neither the polymers nor any ions released into the body upon ion exchange are harmful.
  • the ions released into the body are actually beneficial to the patient.
  • the exchangeable ions are natural nutrients such as amino acids.
  • stable it is meant that when ingested in therapeutically effective amounts the polymers do not dissolve or otherwise decompose to form potentially harmful by-products, and remain substantially intact so that they can transport ions following ion exchange out of the body.
  • the polymer is crosslinked by means of a multifunctional crosslinking co-monomer, the co-monomer being present in an amount from about 1-25% (more preferably about 2.5-20%) by weight, based upon total monomer weight.
  • the polymer further preferably includes one or more hydrophobic co-monomers, e.g., styrene, vinyl naphthalene, ethyl vinylbenzene, N-alkyl and N-aryl derivatives of acrylamide and methacrylamide, alkyl and aryl acrylates, alkyl and aryl methacrylates, and fluorinated derivatives of any of these co-monomers (e.g., p-fluorostyrene, pentafluorostyrene, hexafluoroisopropylacrylate, hexafluorobutylmethacrylate, or heptadecafluorodecylmethacrylate) .
  • the alkyl groups are preferably C 1 -C 15 alkyl groups, and may be straight chain, branched, or cyclic (e.g., cyclohexyl) , and may further be substituted or unsubstituted.
  • the aryl groups preferably have one or more rings and may be substituted or unsubstituted, e.g., phenyl, naphthyl, imidazolyl, or pyridyl.
  • the polymer may also include one or more positively charged co-monomers, e.g., vinyl pyridine, dimethylaminomethyl styrene, or vinyl imidazole.
  • the polymer may further include, as a co-monomer, one or more of the following: n- butyl ethacrylamide, hexafluorobutylmethacrylate, heptadecafluorodecylmethacrylate, styrene or fluorinated derivatives thereof, 2-vinyl naphthalene, 4-vinyl imidazole, vinyl pyridine, trimethylammoniumethylmethacrylate, or trimethylammoniumethylacrylate.
  • a second example of a preferred polymer is characterized by a repeat unit having the formula
  • the polymer may also include, as a co-monomer, one or more of the following: isopropylacrylamide, styrene or fluorinated derivatives thereof, hexafluoroisopropylacrylate, and trimethylammoniumethyl ethacry1ate.
  • the polymer may also include, as a co-monomer, styrene or a fluorinated derivative thereof.
  • a fourth example of a preferred polymer is characterized by a repeat unit having the formula
  • a fifth example of a preferred polymer is characterized by a repeat unit having the formula
  • a sixth example of a preferred polymer is characterized by a repeat unit having the formula
  • the polymer may further include, as a co-monomer, ethyl vinylbenzene.
  • a seventh example of a preferred polymer is characterized by a repeat unit having the formula
  • the polymers may have fixed positive charges, or may have the capability of becoming charged upon ingestion at physiological pH. In the latter case, the charged ions also pick up negatively charged counterions upon ingestion that can be exchanged with bile salts. In the case of polymers having fixed positive charges, however, the polymer may be provided with one or more exchangeable counterions.
  • suitable counterions include CI " , Br ⁇ , CH 3 OS0 3 " , HS0 4 " , S0 4 2" , HC0 3 ⁇ , C0 3 ", acetate, lactate, succinate, propionate, butyrate, ascorbate, citrate, maleate, folate, an amino acid derivative, a nucleotide, a lipid, or a phospholipid.
  • the counterions may be the same as, or different from, each other.
  • the polymer may contain two different types of counterions, both of which are exchanged for the bile salts being removed. More than one polymer, each having different counterions associated with the fixed charges, may be administered as well.
  • the invention also features therapeutic compositions for removing bile salts that include a therapeutically effective amount of one or more of the above-described polymers.
  • the invention features a highly crosslinked polymer composition that includes a polymer characterized by a repeat unit having the formula
  • R 1 is H or methyl
  • Q is -NH-(CH 2 ) 3 - or -0-(CH 2 ) 2 and n is an integer, and at least one additional co-monomer selected from the group consisting essentially of vinylnaphthalene, vinylimidazole, fluorinated derivatives of styrene, and fluorinated alkyl methacrylates.
  • R 1 is methyl and Q is -NH-(CH 2 ) 3 -.
  • This polymer may further comprise, as a co-monomer, trimethylammoniumethylacrylate or trimethylammoniumethylmethacrylate.
  • Q is -0-(CH 2 ) .
  • fluorinated styrene derivatives examples include p-fluorostyrene and pentafluorostyrene.
  • suitable fluorinated alkyl methacrylates include hexafluorobutyl methacrylate and heptadecafluorodecyl methacrylate.
  • the invention features a highly crosslinked polymer composition that includes a polymer characterized by a repeat unit having the formula
  • R 1 is H or methyl
  • Q is -NH-(CH 2 ) 3 - or -0-(CH 2 ) 2 and n is an integer, and, as additional co-monomers, (a) styrene and (b) trimethylammoniumethylacrylate or trimethylam oniumethylmethacrylate when R 1 is methyl and Q is -NH-(CH 2 ) 3 -, and methylacrylamidopropyltrimethylammonium when R 1 is H or methyl and Q is -0-(CH 2 ) .
  • the invention features a method of synthesizing a highly crosslinked polymer having hydrophilic and hydrophobic units that includes reacting hydrophilic and hydrophobic monomers in the presence of an alcoholic solvent.
  • the invention provides an effective treatment for removing bile salts from a patient (and thereby reducing the patient's cholesterol level) .
  • the compositions are non-toxic and stable when ingested in therapeutically effective amounts. They are also tasteless (in the absence of added flavoring) and odorless, as well as being non-constipating and non-gritty (when measured relative to gels such as cholestyramine) such that irritation to the gastrointestinal tract upon ingestion is minimized.
  • the invention further provides an effective synthesis for polymers having hydrophilic and hydrophobic units by conducting the reaction in the presence of an alcoholic solvent not normally considered a good polymerization solvent due to its chain transfer properties.
  • Preferred polymers have the formulae set forth in the Summary of the Invention, above.
  • the polymers are highly crosslinked.
  • the high level of crosslinking makes the polymers completely insoluble and thus limits their activity to the gastrointestinal tract only.
  • the polymers are non-systemic in their activity and will lead to reduced side-effects in the patient.
  • the polymers are preferably crosslinked by adding a crosslinking co-monomer to the reaction mixture during polymerization.
  • suitable crosslinking co-monomers are diacrylates and dimethacrylates (e.g., ethylene glycol diacrylate, propylene glycol diacrylate, butylene glycol diacrylate, ethylene glycol dimethacrylate, propylene glycol dimethacrylate, butylene glycol dimethacrylate, polyethyleneglycol dimethacrylate, polyethyleneglycol diacrylate) , methylene bisacrylamide, methylene bismethacrylamide, ethylene bisacrylamide, ethylenebismethacryla ide, ethylidene bisacrylamide, divinyl benzene, bisphenol A dimethacrylate, and bisphenol A diacrylate.
  • diacrylates and dimethacrylates e.g., ethylene glycol diacrylate, propylene glycol diacrylate, butylene glycol diacrylate, ethylene glycol dimeth
  • crosslinking monomers are either commercially available or are prepared as described in Mandeville et al., "Process for Adjusting Ion Concentration in a Patient and Compositions Therefor," U.S.S.N. 08/065,113, filed May 20, 1993, assigned to the same assignee as the present application and hereby incorporated by reference.
  • the amount of crosslinking co-monomer is typically between 1.0 and 25 weight %, based upon combined weight of crosslinking co- monomer and monomer, with 2.5-20% being preferred.
  • the polymer includes one or more co- monomers that increase the overall hydrophobicity of the polymer.
  • hydrophobic co-monomers aids in maximizing the selectivity of the interaction of the polymer with the bile salts.
  • suitable hydrophobic co-monomers include, e.g., acrylamide, methacrylamide, and N-alkyl (e.g., methyl, ethyl, isopropyl, butyl, hexyl, dodecyl, cyclohexyl, dicyclohexyl) and N-aryl (e.g., phenyl, diphenyl) derivatives thereof; alkyl and aryl acrylates and methacrylates (e.g., ethyl, propyl, butyl, dodecyl), and fluorinated derivatives thereof (e.g., hexafluoroisopropyl acrylate, hexafluorobutyl " methacrylate, heptadecafluorodecyl
  • the level of hydrophobicity needed may also be achieved simply by appropriate choice of crosslinking co- monomer.
  • divinylbenzene is a suitable crosslinking co-monomer and is hydrophobic as well.
  • the main "impurity" in divinylbenzene is ethylvinylbenzene, a hydrophobic, polymerizable monomer which will also contribute to the overall hydrophobicity of the polymer.
  • Other hydrophobic crosslinking co- monomers include bisphenol A diacrylate and bisphenol A dimethacrylate. Examples A. Polymer Preparation
  • methacrylamidopropyltrimethylammonium chloride (MAPTAC) (40 mL of a 50% aqueous solution, 21 g) , ethylene glycol dimethacrylate crosslinking co-monomer (5.00 g, 4.76 mL) , ethyl acetate (200 mL) , and 2-propanol (200 mL) .
  • MTAC methacrylamidopropyltrimethylammonium chloride
  • AIBN 0.1 g
  • the solution was degassed with nitrogen for 5 minutes, at which point it turned cloudy, indicating that polymerization was proceeding.
  • the reaction was maintained at 65°C for another 3 hours and then allowed to cool to room temperature.
  • the resulting polymer (which was hard and sticky) was combined with 500 mL of water to soften it, and then transferred to a blender where it was blended with 1500 mL of 2-propanol and centrifuged. The mixture was then decanted and transferred to another blender with the aid of 100 mL of water. 800 mL of 2-propanol was then added and the mixture was blended, allowed to settle, and decanted.
  • PolyMAPTAC crosslinked with 0.5% methylenebismethacrylamide crosslinking co-monomer; polyMAP AC crosslinked with 10% methylenebismethacrylamide crosslinking co-monomer; and polyMAPTAC crosslinked with 10% divinylbenzene crosslinking co-monomer were prepared in analogous fashion.
  • the first step involved the preparation of ethylidenebisacetamide.
  • Acetamide (118 g) , acetaldehyde (44.06 g) , copper acetate (0.2 g) , and water (300 L) were placed in a 1 L three neck flask fitted with condenser, thermometer, and mechanical stirrer.
  • Concentrated HCI (34 L) was added and the mixture was heated to 45-50°C with stirring for 24 h.
  • the water was then removed in vacuo to leave a thick sludge which formed crystals on cooling to 5°C.
  • Acetone (200 L) was added and stirred for a few minutes, after which the solid was filtered off and discarded.
  • the acetone was cooled to 0°C and solid was filtered off. This solid was rinsed in 500 mL acetone and air dried 18 h to yield 31.5 g of ethylidenebisacetamide.
  • the next step involved the preparation of vinylacetamide from ethylidenebisacetamide.
  • Ethylidenebisacetamide (31.05 g) , calcium carbonate (2 g) and celite 541 (2 g) were placed in a 500 mL three neck flask fitted with a thermometer, a mechanical stirrer, and a distilling head atop a Vigroux column.
  • the mixture was vacuum distilled at 35 mm Hg by heating the pot to 180-225°C. Only a single fraction was collected (10.8 g) which contained a large portion of acetamide in addition to the product (determined by NMR) .
  • This solid product was dissolved in isopropanol (30 mL) to form the crude vinylacetamide solution used for polymerization.
  • Poly(vinylacetamide) (0.79 g) was placed in a 100 L one neck flask containing water (25 mL) and cone. HCI (25 mL) . The mixture was refluxed for 5 days, after which the solid was filtered off, rinsed once in water, twice in isopropanol, and dried in a vacuum oven to yield 0.77 g of product. Infrared spectroscopy indicated that a significant amount of the amide (1656 cm" 1 ) remained and that not much amine (1606 cm” 1 ) was formed. The product of this reaction (-0.84 g) was suspended in NaOH (46 g) and water (46 g) and heated to boiling ( ⁇ 140°C) .
  • Dimethylaminopropylacryla ide (10 g) and methylenebisacrylamide crosslinking co-monomer (1.1 g) were dissolved in 50 mL of water in a 100 mL three neck flask. The solution was stirred under nitrogen for 10 minutes. Potassium persulfate (0.3 g) and sodium metabisulfite (0.3 g) were each dissolved in 2-3 mL of water and then mixed. After a few seconds this solution was added to the monomer solution, still under nitrogen. A gel formed immediately and was allowed to sit overnight. The gel was removed and blended with 500 mL of isopropanol. The solid was filtered off and rinsed three times with acetone. The solid white powder was filtered off and dried in a vacuum oven to yield 6.1 g.
  • Dimethylaminopropylmethacrylamide (20.0 g) was dissolved in water (100 L) and neutralized with concentrated HCI to pH 6.94.
  • Methylenebisacrylamide crosslinking co-monomer (2.2 g) was added and the solution was warmed (39°C) to dissolve.
  • Potassium persulfate (0.3 g) and potassium metabisulfite (0.3 g) were added with stirring under a nitrogen atmosphere. After gellation, the solution was allowed to sit overnight, blended with isopropanol (500 L) twice, and dried in a vacuum oven to yield 27.65 g of product.
  • the co-monomer n-butylmethacrylamide (BuMA) was prepared as follows. Methacryloyl chloride (48.4mL, 52.3g, 0.500mol) was dissolved in tetrahydrofuran (300 mL) in a 1 L flask and placed in an ice bath. A solution containing butylamine (36.6 g) and triethylamine (55.6 g) was added dropwise, maintaining the temperature at 5-15°C. After addition the solution was stirred for 5 min and the solid triethylamine hydrochloride was filtered off and discarded. The solvent was removed in vacuo from the mother liquor and the resulting yellow oil was used without further purification. The yield was 71.58g of BuMA co-monomer.
  • methacrylamidopropyltrimethylammoniu chloride (MAPTAC) (108 mL of a 50% aqueous solution, 56.8 g) , ethylene glycol dimethacrylate crosslinking co-monomer (19.62 g) , BuMA co-monomer (12.12g), and 2-propanol (850 mL) .
  • MATAC methacrylamidopropyltrimethylammoniu chloride
  • ethylene glycol dimethacrylate crosslinking co-monomer (19.62 g)
  • BuMA co-monomer (12.12g)
  • 2-propanol 850 mL
  • the catalyst consisting of a solution of potassium persulfate (0.75g) and potassium metabisulfate (0.75g) in 25mL of water was added.
  • the solution immediately began to turn cloudy, indicating that polymerization was proceeding.
  • the reaction was maintained at 40°C for 24 hours and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and vacuum dried to afford 64.54 g of the title polymer.
  • Polymer for testing was washed two times with 800mL of water each time, followed by two washes with 500 mL of methanol each time to give 34.5 g of purified polymer.
  • a crosslinked MAPTAC co-BuMA copolymer was also prepared using propylene glycol dimethacrylate, rather than ethylene glycol dimethacrylate, as the crosslinking co-monomer, as follows.
  • methacrylamidopropyltrimethylammonium chloride (MAPTAC) (60 mL of a 50% aqueous solution, 31.5 g) , propylene glycol dimethacrylate crosslinking co-monomer (9.81 g) , BuMA co-monomer (6.06g), and 2-propanol (300 mL) .
  • MTAC methacrylamidopropyltrimethylammonium chloride
  • MAPTAC coBuMA (5%) crosslinked with 24% ethyleneglycoldimethacrylate crosslinking co-monomer, MAPTAC coBuMA (2)%) crosslinked with 0.5% methylenebismethacrylamide crosslinking co-monomer, and MAPTAC coBuMA (14%) crosslinked with 22% propyleneglycoldimethacrylate crosslinking co-monomer were prepared in analogous fashion by adjusting the ratios of starting monomers. 7.
  • methacrylamidopropyltrimethyl-ammonium chloride (MAPTAC) (60 mL of a 50% aqueous solution, 31.5 g) , divinyl benzene crosslinking co-monomer (2.00 g) , styrene co- monomer (1.75g), and 2-propanol (300 mL) .
  • the resulting solution was clear.
  • the reaction mixture was heated to 60°C while being degassed with nitrogen. When the solution had reached 60°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 60°C for 24 hours and then allowed to cool to room temperature.
  • methacrylamidopropyltrimethylammonium chloride (MAPTAC) (40 mL of a 50% aqueous solution, 21.0 g) , divinyl benzene crosslinking co-monomer (2.25 g) , 2- vinylnaphthalene co-monomer (10.5 g) , and 2-propanol (320 mL) .
  • the resulting solution was clear.
  • the reaction mixture was heated to 65°C while being degassed with nitrogen. When the solution had reached 65°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 65°C for 20 hours and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and then immediately slurried in 400 mL of distilled water. The mixture was stirred for 1/2 hour and then filtered. The water wash was repeated one more time. The filter cake was then slurried in 400 mL of methanol and stirred for 1/2 hour. The mixture was filtered and the methanol slurry was repeated one more time. Vacuum drying afforded 22.11 g, 65.5% of the title polymer.
  • MAPTAC co-VN (39%) crosslinked with 5% divinyl benzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of starting monomers.
  • the resulting polymer was filtered and washed on the funnel with isopropanol, and then immediately slurried in 500 mL of distilled water. The mixture was stirred for 1/2 hour and then filtered. The water wash was repeated one more time. The filter cake was then slurried in 400 L of methanol and stirred for 1/2 hour. The mixture was filtered and the methanol slurry was repeated one more time. Vacuum drying afforded 7.34 g, 20.5% of the title polymer.
  • TMAEAC trimethylammoniumethylacrylatechloride
  • the resulting polymer was filtered and washed on the funnel with isopropanol, and then immediately slurried in 1000 mL of distilled water. The mixture was stirred for 1/2 hour and then 800 mL of methanol was added and the mixture was stirred for an additional 1/2 hour. The mixture was allowed to settle and the supernatant liquid was decanted, leaving a residue of about 750 mL. The residue was then slurried with an additional 750 mL of methanol and stirred for 1/2 hour. The methanol slurry and decantation process was repeated two more times with 800 mL of methanol each time. Next, 800 mL of isopropanol was added and the mixture was stirred for 1/2 hour and then filtered.
  • TMAEAC co-Sty (31%) crosslinked with 8% divinylbenzene crosslinking co-monomer and TMAEAC co-Sty (46%) crosslinked with 6% divinylbenzene crosslinking co- monomer were prepared in analogous fashion by varying the ratio of starting monomers. 11.
  • TMAEMC co-Stv Poly(trimethy1ammoniumethylmethacry1ate- chloride co-polv(styrene)
  • TMAEMAC trimethylammoniumethylmethacrylatechloride
  • TMAEMC co-Sty (58%) crosslinked with 4% divinylbenzene crosslinking co-monomer
  • TMAEMC co-Sty (33%) crosslinked with 4% divinylbenzene crosslinking co- monomer
  • TMAEMC co-Sty (24%) crosslinked with 4% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
  • reaction mixture was heated to 65°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. After five hours the mixture was very thick so an additional 100 mL of isopropanol was added. The reaction was maintained at 65°C for 24 hours, and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of distilled water. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and 500 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was filtered and the filter cake was slurried two times in 300 mL of methanol each time. Filtration and air drying afforded 7.74 g of the title co-polymer.
  • MAPTAC co-StyF 5 (20%) crosslinked with 5% divinylbenzene crosslinking co-monomer
  • MAPTAC co-StyF 5 40%) crosslinked with 5% divinylbenzene crosslinking co- monomer
  • MAPTAC co-StyF 5 45% crosslinked with 5% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
  • reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and 400 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was filtered and the water slurry was repeated. The mixture was filtered and the filter cake was slurried two times in 400 mL of methanol each time. Filtration and air drying afforded 5.39 g of the title co-polymer.
  • MAPTAC co-TMAEMC (34%) co-Sty (36%) crosslinked with 5% divinylbenzene crosslinking co-monomer
  • MAPTAC co-TMAEMC (31%) co-Sty (41%) crosslinked with 5% divinylbenzene crosslinking co-monomer
  • MAPTAC co-TMAEMC 28%) co-Sty (46%) crosslinked with 5% divinylbenzene crosslinking co-monomer
  • MAPTAC co-TMAEMC (23%) co-Sty (48%) crosslinked with 5% divinylbenzene crosslinking co- monomer
  • MAPTAC co-TMAEMC (26%) co-Sty (52%) crosslinked with 4% divinylbenzene crosslinking co-monomer
  • MAPTAC co-TMAEMC (17%) co-Sty (53%) crosslinked with 4% divinylbenzene crosslinking co-monomer
  • MAPTAC co-TMAEMC (15%) co-Sty (55
  • the co-monomer isopropylacrylamide (IPA) was first prepared as follows.
  • the gel was transferred to a blender and 1000 mL of water was added. After blending for a few seconds, the polymer had swelled to take up all of the water. The swollen polymer was blended in several portions with isopropanol several times to dehydrate it. The resulting polymer was filtered and washed on the funnel with isopropanol and vacuum dried to afford 36.8 g of the title co-polymer.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 1000 mL of distilled water. The mixture was stirred for 1 hour. The polymer slurry was filtered, washed on the funnel with methanol, and then slurried in 600 mL of methanol for one hour. Filtration and air drying afforded 20.4 g of co-polymer.
  • TMAEMC trimethylammoniumethylmethacrylate chloride
  • TMAEMC co-F ⁇ ty (24%) crosslinked with 4% divinylbenzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of the starting monomers.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of distilled water. The mixture was stirred for 1 hour. The polymer slurry was filtered and the water slurry was repeated one more time. The polymer was then slurried in 500 mL of methanol for one hour and filtered.
  • the residual polymer was slurried in 400 L of water, stirred for one hour and filtered. The water slurry was repeated one more time. Next the polymer was slurried two times in methanol. Finally, the polymer was slurried in 200 mL of isopropanol, stirred for two hours and filtered. Air drying afforded 5.59 g of the title polymer.
  • reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding.
  • the reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/2 hour .
  • the polymer slurry was allowed to settle and decanted.
  • MAPTAC co-TMAEAC (10%) co-Sty (60%) crosslinked with 5% divinylbenzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of starting monomers.
  • TMAEAC 2-(trimethylammonium) ethyl acrylate chloride
  • TMAEAC co-StyF 5 (20%) crosslinked with 5% divinylbenzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of starting monomers.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 L of distilled water. The mixture was stirred for 1/4 hour. The polymer slurry was filtered and 500 mL of distilled water was added and the mixture was stirred for 1/4 hour. The water slurry was repeated one more time. The mixture was filtered and the filter cake was slurried three times in 300 mL of methanol each time. Filtration and air drying afforded 1.26 g of the title co-polymer.
  • TMAEMC co-StyF 5 (24%) crosslinked with 4% divinylbenzene crosslinking co-monomer
  • TMAEMC co- StyF 5 (39%) crosslinked with 4% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
  • reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/4 hour. The polymer slurry was filtered and then slurried 3 times in 300 mL of water each time. The last time the polymer slurry was blended for 5 minutes. The mixture was filtered and the filter cake was slurried two times in
  • TMAEAC 2-(trimethylammonium) ethyl acrylate chloride
  • TMAEMC 2-(trimethylammonium) ethyl methacrylate chloride
  • divinylbenzene crosslinking co-monomer (1.00 g)
  • styrene 13.00 g
  • 2-propanol 150 mL
  • AIBN AIBN
  • reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
  • the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding.
  • the reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
  • the resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 400 mL of methanol. The mixture was stirred for 1/2 hour.
  • the polymer slurry was filtered and then slurried 2 times in 250 mL of water each time. The last time the polymer slurry was blended for 5 minutes.
  • the mixture was filtered and the filter cake was slurried two times in 250 mL of methanol each time. Filtration and vacuum drying afforded 7.80 g of co-polymer.
  • TMAEAC trimethylammonium ethylmethacrylate chloride
  • TMAEMC co-2,3,4,5,6-pentafluorostyrene
  • TMAEAC 2-(trimethylammonium) ethyl acrylate chloride
  • TMAEMC 2-(trimethylammonium) ethyl methacrylate chloride
  • divinylbenzene crosslinking co-monomer (1.00 g)
  • pentafluorostyrene 13.00 g
  • 2-propanol 150 mL
  • AIBN 0.50g
  • reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
  • the resulting polymer was decanted and immediately slurried in 400 mL of methanol. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and then slurried two times in 200 mL of water each time. The second time the polymer slurry was blended for 5 minutes. The mixture was filtered and the filter cake was slurried two times in 200 mL of methanol each time. Vacuum drying afforded 6.87 g of co-polymer. Testing of Polymers A. Preparation of Artificial Intestinal Fluid
  • Sodium carbonate (1.27g) and sodium chloride (1.87g) were dissolved in 400 mL of distilled water.
  • a mixture of purified bile acids consisting of taurocholic acid (0.138g, 0.24mmol), glycocholic acid (0.292g, 0.60mmol), glycodeoxycholic acid (0.085mmol, O.l ⁇ mmol) and glycochenodeoxycholic acid (0.085mmol, 0.18mmol).
  • the pH of the solution was adjusted to 7.20 with acetic acid. This solution was used for the testing of the various polymers.
  • the total bile salt concentration in this solution is 3 millimolar, a concentration approximately equal to that found in normal physiological solutions in the duodenum. Polymers were tested as follows.
  • NAD+ solution containing 7mM NAD+ at pH 7.0.
  • HSD solution containing 2units/mL in Tris-HCl buffer (0.03M Tris, ImM EDTA) at pH 7.2.
  • the polymers according to the invention may be administered orally to a patient in a dosage of about 1 mg/kg/day to about 10 g/kg/day; the particular dosage will depend on the individual patient (e.g., the patient's weight and the extent of bile salt removal required) .
  • the polymer may be administrated either in hydrated or dehydrated form, and may be flavored if necessary to enhance patient acceptability; additional ingredients such as artificial coloring agents may be added as well.
  • suitable forms for administration include pills, tablets, capsules, and powders (for sprinkling on food) .
  • the pill, tablet, capsule, or powder can be coated with a substance capable of protecting the composition from the gastric acid in the patient's stomach for a period of time sufficient to allow the composition to pass undisintegrated into the patient's small intestine.
  • the polymer may be administered alone or in combination with a pharmaceutically acceptable carrier substance, e.g., magnesium carbonate, lactose, or a phospholipid with which the polymer can form a micelle.

Abstract

A method for removing bile salts from a patient by ion exchange by administering to the patient a therapeutically effective amount of one or more highly crosslinked polymers characterized by a repeat unit having formula (1) or copolymer thereof, where n is an integer; R1 is H or a C¿1?-C8 alkyl group; M is -C-Z-R?2? or -Z-R?2¿; Z is O, NR3, S, or (CH¿2?)m; m = 0-10; R?3¿ is H or a C¿1?-C8 alkyl group; and R?2¿ is (a) or (b) where p = 0-10, and each R?4, R5, R6¿, independently, is H, a C¿1?-C8 alkyl group, or an aryl group, the polymers being non-toxic and stable once ingested.

Description

COMPOSITIONS AND PROCESS FOR REMOVING BILE SALTS
Background of the Invention This invention relates to removing bile salts from a patient.
Sequestering and removing bile salts (e.g., cholate, glycocholate, glycochenocholate, taurocholate, and deoxycholate salts) in a patient can be used to reduce the patient's cholesterol level. Ion exchange resins which, when ingested, remove bile salts via the digestive tract, have been used for this purpose. Removal of bile salts will cause the body to prepare more bile salts. Because the biological precursor to bile salt is cholesterol, the metabolism of cholesterol to make bile salts is accompanied by a simultaneous reduction in the cholesterol in the patient.
Summary of the Invention In a first aspect, the invention features a method of removing bile salts from a patient by ion exchange that includes administering to the patient a therapeutically effective amount of one or more highly crosslinked polymers that are non-toxic and stable once ingested. The polymers are characterized by a repeat unit having the formula
I
* >- « ,*, (i)
or copolymer thereof, where n is an integer; R1 is H or a ci"" 8 allζyl group (which may be straight chain or branched. O substituted or unsubstituted, e.g., methyl); M is -C-Z-R2 or -Z-R2; Z is O, NR3, S, or (CH2)m; m = 0-10; R3 is H or a CJ-C8 alkyl group (which may be straight chain or branched, substituted or unsubstituted, e.g., methyl); and R2 is
where p = 0-10, and each R4, R5, and R6, independently, is H, a CJL-CQ alkyl group (which may be straight chain or branched, substituted or unsubstituted, e.g. , methyl) , or an aryl group (e.g., having one or more rings and which may be substituted or unsubstituted, e.g., phenyl, naphthyl, imidazolyl, or pyridyl) .
By "non-toxic" it is meant that when ingested in therapeutically effective amounts neither the polymers nor any ions released into the body upon ion exchange are harmful. Preferably, the ions released into the body are actually beneficial to the patient. Such is the case when, for example, the exchangeable ions are natural nutrients such as amino acids.
By "stable" it is meant that when ingested in therapeutically effective amounts the polymers do not dissolve or otherwise decompose to form potentially harmful by-products, and remain substantially intact so that they can transport ions following ion exchange out of the body.
In preferred embodiments, the polymer is crosslinked by means of a multifunctional crosslinking co-monomer, the co-monomer being present in an amount from about 1-25% (more preferably about 2.5-20%) by weight, based upon total monomer weight. The polymer further preferably includes one or more hydrophobic co-monomers, e.g., styrene, vinyl naphthalene, ethyl vinylbenzene, N-alkyl and N-aryl derivatives of acrylamide and methacrylamide, alkyl and aryl acrylates, alkyl and aryl methacrylates, and fluorinated derivatives of any of these co-monomers (e.g., p-fluorostyrene, pentafluorostyrene, hexafluoroisopropylacrylate, hexafluorobutylmethacrylate, or heptadecafluorodecylmethacrylate) . The alkyl groups are preferably C1-C15 alkyl groups, and may be straight chain, branched, or cyclic (e.g., cyclohexyl) , and may further be substituted or unsubstituted. The aryl groups preferably have one or more rings and may be substituted or unsubstituted, e.g., phenyl, naphthyl, imidazolyl, or pyridyl. The polymer may also include one or more positively charged co-monomers, e.g., vinyl pyridine, dimethylaminomethyl styrene, or vinyl imidazole.
One example of a preferred polymer is characterized by a repeat unit having the formula
or copolymer thereof. The polymer may further include, as a co-monomer, one or more of the following: n- butyl ethacrylamide, hexafluorobutylmethacrylate, heptadecafluorodecylmethacrylate, styrene or fluorinated derivatives thereof, 2-vinyl naphthalene, 4-vinyl imidazole, vinyl pyridine, trimethylammoniumethylmethacrylate, or trimethylammoniumethylacrylate. A second example of a preferred polymer is characterized by a repeat unit having the formula
(3)
0-fcc λ- jS CΛ
or copolymer thereof. The polymer may also include, as a co-monomer, one or more of the following: isopropylacrylamide, styrene or fluorinated derivatives thereof, hexafluoroisopropylacrylate, and trimethylammoniumethyl ethacry1ate.
A third example of a preferred polymer is characterized by a repeat unit having the formula
or copolymer thereof. The polymer may also include, as a co-monomer, styrene or a fluorinated derivative thereof. A fourth example of a preferred polymer is characterized by a repeat unit having the formula
or copolymer thereof. A fifth example of a preferred polymer is characterized by a repeat unit having the formula
or copolymer thereof. A sixth example of a preferred polymer is characterized by a repeat unit having the formula
1L
or copolymer thereof. The polymer may further include, as a co-monomer, ethyl vinylbenzene. A seventh example of a preferred polymer is characterized by a repeat unit having the formula
-^M - U^ O^ (8)
or copolymer thereof.
The polymers may have fixed positive charges, or may have the capability of becoming charged upon ingestion at physiological pH. In the latter case, the charged ions also pick up negatively charged counterions upon ingestion that can be exchanged with bile salts. In the case of polymers having fixed positive charges, however, the polymer may be provided with one or more exchangeable counterions. Examples of suitable counterions include CI", Br~, CH3OS03 ", HS04 ", S04 2", HC03 ~ , C03", acetate, lactate, succinate, propionate, butyrate, ascorbate, citrate, maleate, folate, an amino acid derivative, a nucleotide, a lipid, or a phospholipid. The counterions may be the same as, or different from, each other. For example, the polymer may contain two different types of counterions, both of which are exchanged for the bile salts being removed. More than one polymer, each having different counterions associated with the fixed charges, may be administered as well.
The invention also features therapeutic compositions for removing bile salts that include a therapeutically effective amount of one or more of the above-described polymers.
In another aspect, the invention features a highly crosslinked polymer composition that includes a polymer characterized by a repeat unit having the formula
where R1 is H or methyl, Q is -NH-(CH2)3- or -0-(CH2)2 and n is an integer, and at least one additional co-monomer selected from the group consisting essentially of vinylnaphthalene, vinylimidazole, fluorinated derivatives of styrene, and fluorinated alkyl methacrylates. In some preferred embodiments of this aspect, R1 is methyl and Q is -NH-(CH2)3-. This polymer may further comprise, as a co-monomer, trimethylammoniumethylacrylate or trimethylammoniumethylmethacrylate. In other preferred embodiments, Q is -0-(CH2) . Examples of suitable fluorinated styrene derivatives include p-fluorostyrene and pentafluorostyrene. Examples of suitable fluorinated alkyl methacrylates include hexafluorobutyl methacrylate and heptadecafluorodecyl methacrylate.
In yet another aspect, the invention features a highly crosslinked polymer composition that includes a polymer characterized by a repeat unit having the formula
where R1 is H or methyl, Q is -NH-(CH2)3- or -0-(CH2)2 and n is an integer, and, as additional co-monomers, (a) styrene and (b) trimethylammoniumethylacrylate or trimethylam oniumethylmethacrylate when R1 is methyl and Q is -NH-(CH2)3-, and methylacrylamidopropyltrimethylammonium when R1 is H or methyl and Q is -0-(CH2) .
In an additional aspect, the invention features a method of synthesizing a highly crosslinked polymer having hydrophilic and hydrophobic units that includes reacting hydrophilic and hydrophobic monomers in the presence of an alcoholic solvent.
The invention provides an effective treatment for removing bile salts from a patient (and thereby reducing the patient's cholesterol level) . The compositions are non-toxic and stable when ingested in therapeutically effective amounts. They are also tasteless (in the absence of added flavoring) and odorless, as well as being non-constipating and non-gritty (when measured relative to gels such as cholestyramine) such that irritation to the gastrointestinal tract upon ingestion is minimized.
The invention further provides an effective synthesis for polymers having hydrophilic and hydrophobic units by conducting the reaction in the presence of an alcoholic solvent not normally considered a good polymerization solvent due to its chain transfer properties. Other features and advantages will be apparent from the following description of the preferred embodiments thereof and from the claims.
Description of the Preferred Embodiments Compositions Preferred polymers have the formulae set forth in the Summary of the Invention, above. The polymers are highly crosslinked. The high level of crosslinking makes the polymers completely insoluble and thus limits their activity to the gastrointestinal tract only. Thus, the polymers are non-systemic in their activity and will lead to reduced side-effects in the patient.
The polymers are preferably crosslinked by adding a crosslinking co-monomer to the reaction mixture during polymerization. Examples of suitable crosslinking co-monomers are diacrylates and dimethacrylates (e.g., ethylene glycol diacrylate, propylene glycol diacrylate, butylene glycol diacrylate, ethylene glycol dimethacrylate, propylene glycol dimethacrylate, butylene glycol dimethacrylate, polyethyleneglycol dimethacrylate, polyethyleneglycol diacrylate) , methylene bisacrylamide, methylene bismethacrylamide, ethylene bisacrylamide, ethylenebismethacryla ide, ethylidene bisacrylamide, divinyl benzene, bisphenol A dimethacrylate, and bisphenol A diacrylate. These crosslinking monomers are either commercially available or are prepared as described in Mandeville et al., "Process for Adjusting Ion Concentration in a Patient and Compositions Therefor," U.S.S.N. 08/065,113, filed May 20, 1993, assigned to the same assignee as the present application and hereby incorporated by reference. The amount of crosslinking co-monomer is typically between 1.0 and 25 weight %, based upon combined weight of crosslinking co- monomer and monomer, with 2.5-20% being preferred. Preferably, the polymer includes one or more co- monomers that increase the overall hydrophobicity of the polymer. Because bile salts are hydrophobic, the hydrophobic co-monomer aids in maximizing the selectivity of the interaction of the polymer with the bile salts. Examples of suitable hydrophobic co-monomers include, e.g., acrylamide, methacrylamide, and N-alkyl (e.g., methyl, ethyl, isopropyl, butyl, hexyl, dodecyl, cyclohexyl, dicyclohexyl) and N-aryl (e.g., phenyl, diphenyl) derivatives thereof; alkyl and aryl acrylates and methacrylates (e.g., ethyl, propyl, butyl, dodecyl), and fluorinated derivatives thereof (e.g., hexafluoroisopropyl acrylate, hexafluorobutyl" methacrylate, heptadecafluorodecyl acrylate) ; styrene and derivatives thereof (e.g., dimethylaminomethyl styrene and fluorinated derivatives, e.g., p- fluorostyrene, pentafluorostyrene) ; ethylvinylbenzene; vinyl naphthalene; vinyl pyridine; and vinyl imidazole. The amount of hydrophobic co-monomer used in the preparation of these polymers is from l to 75% by weight, preferably from 3 to 65%.
The level of hydrophobicity needed may also be achieved simply by appropriate choice of crosslinking co- monomer. For example, divinylbenzene is a suitable crosslinking co-monomer and is hydrophobic as well. In addition, the main "impurity" in divinylbenzene is ethylvinylbenzene, a hydrophobic, polymerizable monomer which will also contribute to the overall hydrophobicity of the polymer. Other hydrophobic crosslinking co- monomers include bisphenol A diacrylate and bisphenol A dimethacrylate. Examples A. Polymer Preparation
1. Preparation of Poly
(methacrylamidopropyltrimethylammonium chloride. fPolvMAPTAC.
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: methacrylamidopropyltrimethylammonium chloride (MAPTAC) (40 mL of a 50% aqueous solution, 21 g) , ethylene glycol dimethacrylate crosslinking co-monomer (5.00 g, 4.76 mL) , ethyl acetate (200 mL) , and 2-propanol (200 mL) . The resulting solution was clear. Next, the polymerization initiator AIBN (0.1 g) was added and the reaction mixture was heated to 65°C. When the temperature reached 65°C, the solution was degassed with nitrogen for 5 minutes, at which point it turned cloudy, indicating that polymerization was proceeding. The reaction was maintained at 65°C for another 3 hours and then allowed to cool to room temperature. The resulting polymer (which was hard and sticky) was combined with 500 mL of water to soften it, and then transferred to a blender where it was blended with 1500 mL of 2-propanol and centrifuged. The mixture was then decanted and transferred to another blender with the aid of 100 mL of water. 800 mL of 2-propanol was then added and the mixture was blended, allowed to settle, and decanted. The mixture was then combined with 1000 mL of 2-propanol, blended, filtered, and vacuum-dried to afford 12.6 g of polymer. PolyMAPTAC crosslinked with 0.5% methylenebismethacrylamide crosslinking co-monomer; polyMAP AC crosslinked with 10% methylenebismethacrylamide crosslinking co-monomer; and polyMAPTAC crosslinked with 10% divinylbenzene crosslinking co-monomer were prepared in analogous fashion.
2. Preparation of Poly (vinylamine) The first step involved the preparation of ethylidenebisacetamide. Acetamide (118 g) , acetaldehyde (44.06 g) , copper acetate (0.2 g) , and water (300 L) were placed in a 1 L three neck flask fitted with condenser, thermometer, and mechanical stirrer. Concentrated HCI (34 L) was added and the mixture was heated to 45-50°C with stirring for 24 h. The water was then removed in vacuo to leave a thick sludge which formed crystals on cooling to 5°C. Acetone (200 L) was added and stirred for a few minutes, after which the solid was filtered off and discarded. The acetone was cooled to 0°C and solid was filtered off. This solid was rinsed in 500 mL acetone and air dried 18 h to yield 31.5 g of ethylidenebisacetamide.
The next step involved the preparation of vinylacetamide from ethylidenebisacetamide. Ethylidenebisacetamide (31.05 g) , calcium carbonate (2 g) and celite 541 (2 g) were placed in a 500 mL three neck flask fitted with a thermometer, a mechanical stirrer, and a distilling head atop a Vigroux column. The mixture was vacuum distilled at 35 mm Hg by heating the pot to 180-225°C. Only a single fraction was collected (10.8 g) which contained a large portion of acetamide in addition to the product (determined by NMR) . This solid product was dissolved in isopropanol (30 mL) to form the crude vinylacetamide solution used for polymerization.
Crude vinylacetamide solution (15 mL) , divinylbenzene (1 g, technical grade, 55% pure, mixed isomers) , and AIBN (0.3 g) were mixed and heated to reflux under a nitrogen atmosphere for 90 min, forming a solid precipitate. The solution was cooled, isopropanol (50 L) was added, and the solid was collected by centrifugation. The solid was rinsed twice in isopropanol, once in water, and dried in a vacuum oven to yield 0.8 g of poly(vinylacetamide) , which was used to prepare poly(vinylamine as follows) .
Poly(vinylacetamide) (0.79 g) was placed in a 100 L one neck flask containing water (25 mL) and cone. HCI (25 mL) . The mixture was refluxed for 5 days, after which the solid was filtered off, rinsed once in water, twice in isopropanol, and dried in a vacuum oven to yield 0.77 g of product. Infrared spectroscopy indicated that a significant amount of the amide (1656 cm"1) remained and that not much amine (1606 cm"1) was formed. The product of this reaction (-0.84 g) was suspended in NaOH (46 g) and water (46 g) and heated to boiling (~140°C) . Due to foaming the temperature was reduced and maintained at ~100°C for 2 h. Water (100 mL) was added and the solid collected by filtration. After rinsing once in water the solid was suspended in water (500 mL) and adjusted to pH 5 with acetic acid. The solid was again filtered off, rinsed with water, then isopropanol, and dried in a vacuum oven to yield 0.51 g of product. Infrared spectroscopy indicated that significant amine had been formed.
3. Preparation of
Poly(3-dimethylaminopropylacrylamide. (DMAPA.
Dimethylaminopropylacryla ide (10 g) and methylenebisacrylamide crosslinking co-monomer (1.1 g) were dissolved in 50 mL of water in a 100 mL three neck flask. The solution was stirred under nitrogen for 10 minutes. Potassium persulfate (0.3 g) and sodium metabisulfite (0.3 g) were each dissolved in 2-3 mL of water and then mixed. After a few seconds this solution was added to the monomer solution, still under nitrogen. A gel formed immediately and was allowed to sit overnight. The gel was removed and blended with 500 mL of isopropanol. The solid was filtered off and rinsed three times with acetone. The solid white powder was filtered off and dried in a vacuum oven to yield 6.1 g.
4. Preparation of
Poly(dimethylaminopropylacrylamide hvdrochloride. fDMAPA-HCl. Dimethylaminopropylacrylamide (20.10 g) was dissolved in water (100 mL) and neutralized with concentrated HCI to pH 6.95. Methylenebisacrylamide crosslinking co-monomer (2.2 g) and water (100 mL) were added and warmed (34°C) to dissolve. Potassium persulfate (0.2 g) and potassium metabisulfite (0.2 g) were added with stirring. After gellation, the solution was allowed to sit for 6 h, blended with isopropanol (600 mL) three times, and dried in a vacuum oven to yield 14.47 g of the title polymer. PolyDMAPA-HCI crosslinked with 10% methylenebismethacrylamide crosslinking co-monomer was prepared in analogous fashion.
5. Preparation of
Poly(dimethylaminopropylmethacrylamide hvdrochloride. (DMAPMA-HC1.
Dimethylaminopropylmethacrylamide (20.0 g) was dissolved in water (100 L) and neutralized with concentrated HCI to pH 6.94. Methylenebisacrylamide crosslinking co-monomer (2.2 g) was added and the solution was warmed (39°C) to dissolve. Potassium persulfate (0.3 g) and potassium metabisulfite (0.3 g) were added with stirring under a nitrogen atmosphere. After gellation, the solution was allowed to sit overnight, blended with isopropanol (500 L) twice, and dried in a vacuum oven to yield 27.65 g of product. Some of the solid (3.2 g; sieved to -80/+200 mesh size) was stirred in water (100 L) for 50 min, additional water (100 mL) was added and the solution stirred for 36 min. The solid was collected by centrifugation, resuspended in water (400 mL) , stirred 150 min, and again collected by centrifugation. The solid was finally resuspended in water (500 L) , stirred
90 min, and collected by filtration. The solid was dried in a vacuum oven to yield 0.28 g of the title polymer.
6. Preparation of Poly(methacrylamidopropyltrimethylammonium chloride) co-poly(n-butylmethacrylamide) (MAPTAC CO-BuMA.
The co-monomer n-butylmethacrylamide (BuMA) was prepared as follows. Methacryloyl chloride (48.4mL, 52.3g, 0.500mol) was dissolved in tetrahydrofuran (300 mL) in a 1 L flask and placed in an ice bath. A solution containing butylamine (36.6 g) and triethylamine (55.6 g) was added dropwise, maintaining the temperature at 5-15°C. After addition the solution was stirred for 5 min and the solid triethylamine hydrochloride was filtered off and discarded. The solvent was removed in vacuo from the mother liquor and the resulting yellow oil was used without further purification. The yield was 71.58g of BuMA co-monomer.
To a 1000 L, three-necked flask, round-bottomed flask was added the following: methacrylamidopropyltrimethylammoniu chloride (MAPTAC) (108 mL of a 50% aqueous solution, 56.8 g) , ethylene glycol dimethacrylate crosslinking co-monomer (19.62 g) , BuMA co-monomer (12.12g), and 2-propanol (850 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 40°C while being degassed with nitrogen. When the solution had reached 40°C, the catalyst, consisting of a solution of potassium persulfate (0.75g) and potassium metabisulfate (0.75g) in 25mL of water was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 40°C for 24 hours and then allowed to cool to room temperature. The resulting polymer was filtered and washed on the funnel with isopropanol and vacuum dried to afford 64.54 g of the title polymer.
Polymer for testing was washed two times with 800mL of water each time, followed by two washes with 500 mL of methanol each time to give 34.5 g of purified polymer.
A crosslinked MAPTAC co-BuMA copolymer was also prepared using propylene glycol dimethacrylate, rather than ethylene glycol dimethacrylate, as the crosslinking co-monomer, as follows.
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: methacrylamidopropyltrimethylammonium chloride (MAPTAC) (60 mL of a 50% aqueous solution, 31.5 g) , propylene glycol dimethacrylate crosslinking co-monomer (9.81 g) , BuMA co-monomer (6.06g), and 2-propanol (300 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. When the solution had reached 70°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 6 hours and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and vacuum dried to afford 23.3 g of polymer.
MAPTAC coBuMA (5%) crosslinked with 24% ethyleneglycoldimethacrylate crosslinking co-monomer, MAPTAC coBuMA (2)%) crosslinked with 0.5% methylenebismethacrylamide crosslinking co-monomer, and MAPTAC coBuMA (14%) crosslinked with 22% propyleneglycoldimethacrylate crosslinking co-monomer were prepared in analogous fashion by adjusting the ratios of starting monomers. 7. Preparation of
Poly(methacrylamidopropyltrimethylammonium chloride) co-poly(styrene) (MAPTAC co-Stv.
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: methacrylamidopropyltrimethyl-ammonium chloride (MAPTAC) (60 mL of a 50% aqueous solution, 31.5 g) , divinyl benzene crosslinking co-monomer (2.00 g) , styrene co- monomer (1.75g), and 2-propanol (300 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 60°C while being degassed with nitrogen. When the solution had reached 60°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 60°C for 24 hours and then allowed to cool to room temperature.
After about 7 hours the mixture had become very thick and 100 mL additional isopropanol was added to allow for better stirring.
The resulting polymer was filtered and washed on the funnel with isopropanol and vacuum dried to afford 30.9 g of the title polymer.
Polymer for testing was washed two times with 1000 mL of water each time followed by two washes with 800 mL of methanol each time to give 28.0 g of purified polymer. MAPTAC co-Sty (13%) crosslinked with 7.5% butyleneglycoldimethacrylate crosslinking co-monomer, MAPTAC co-Sty (13%) crosslinked with 20% butyleneglycoldimethacrylate crosslinking co-monomer, MAPTAC co-Sty (19%) crosslinked with 6% divinylbenzene co-monomer, MAPTAC co-Sty (23%) crosslinked with 7% divinylbenzene co-monomer, MAPTAC co-Sty (30%) crosslinked with 6% divinylbenzene co-monomer, and MAPTAC co-Sty (38%) crosslinked with 6% divinylbenzene co- monomer were prepared in analogous fashion by varying the ratios of starting monomers. 8. Preparation of
Poly(methacrylamidopropyltrimethylammonium chloride) co-poly(vinyl naphthalene) (MAPTAC co-VN.
To a 1000 mL, three-necked, round-bottomed flask was added the following: methacrylamidopropyltrimethylammonium chloride (MAPTAC) (40 mL of a 50% aqueous solution, 21.0 g) , divinyl benzene crosslinking co-monomer (2.25 g) , 2- vinylnaphthalene co-monomer (10.5 g) , and 2-propanol (320 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. When the solution had reached 65°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 65°C for 20 hours and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and then immediately slurried in 400 mL of distilled water. The mixture was stirred for 1/2 hour and then filtered. The water wash was repeated one more time. The filter cake was then slurried in 400 mL of methanol and stirred for 1/2 hour. The mixture was filtered and the methanol slurry was repeated one more time. Vacuum drying afforded 22.11 g, 65.5% of the title polymer.
MAPTAC co-VN (39%) crosslinked with 5% divinyl benzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of starting monomers. 9. Preparation of
Poly(methacrylamidopropyltrimethylammonium chloride) co-poly(1-vinyl imidazole) (MAPTAC co-VI) To a 1000 mL, three-necked, round-bottomed flask was added the following: methacrylamidopropyltrimethylammonium chloride (MAPTAC)
(40 mL of a 50% aqueous solution, 21.0 g) , divinyl benzene crosslinking co-monomer (2.25 g) , 1- vinylimidazole co-monomer (12.54 g) , and 2-propanol (300 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. When the solution had reached 65°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 65°C for 20 hours and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol, and then immediately slurried in 500 mL of distilled water. The mixture was stirred for 1/2 hour and then filtered. The water wash was repeated one more time. The filter cake was then slurried in 400 L of methanol and stirred for 1/2 hour. The mixture was filtered and the methanol slurry was repeated one more time. Vacuum drying afforded 7.34 g, 20.5% of the title polymer.
10. Preparation of
Poly(trimethylammoniumethylacrylatechloride) co-polv(styrene. (TMAEAC co-Sty)
To a 1000 mL, three-necked, round-bottomed flask was added the following: trimethylammoniumethylacrylatechloride (TMAEAC) (99.4 mL of a 50% aqueous solution, 53.0 g) , divinyl benzene crosslinking co-monomer (7.00 g) , styrene co-monomer
(40.0 g) , and 2-propanol (800 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. When the solution had reached 65°C, the catalyst, AIBN (1.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 65°C for 6 hours, then cooled to 60°C and stirred for an additional 18 hours. It was then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol, and then immediately slurried in 1000 mL of distilled water. The mixture was stirred for 1/2 hour and then 800 mL of methanol was added and the mixture was stirred for an additional 1/2 hour. The mixture was allowed to settle and the supernatant liquid was decanted, leaving a residue of about 750 mL. The residue was then slurried with an additional 750 mL of methanol and stirred for 1/2 hour. The methanol slurry and decantation process was repeated two more times with 800 mL of methanol each time. Next, 800 mL of isopropanol was added and the mixture was stirred for 1/2 hour and then filtered. Finally, 600 mL of isopropanol was added and the mixture was stirred for 1/2 hour. Filtration and vacuum drying afforded 49.2 g, 49.2% of the title polymer. TMAEAC co-Sty (31%) crosslinked with 8% divinylbenzene crosslinking co-monomer and TMAEAC co-Sty (46%) crosslinked with 6% divinylbenzene crosslinking co- monomer were prepared in analogous fashion by varying the ratio of starting monomers. 11. Preparation of
Poly(trimethy1ammoniumethylmethacry1ate- chloride co-polv(styrene) (TMAEMC co-Stv)
To a 1000 L, three-necked, round-bottomed flask was added the following: trimethylammoniumethylmethacrylatechloride (TMAEMAC) (38.8 L of a 50% aqueous solution, 21.7 g) , divinyl benzene crosslinking co-monomer (3.72 g) , styrene co- monomer (15.66 g) , and 2-propanol (2500 mL) . The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. When the solution had reached 65°C, the catalyst, AIBN (0.50g), was added. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. After two hours, the mixture became very thick and an additional 100 mL of isopropanol was added. After five hours the mixture was again very thick so an additional 100 mL of isopropanol was added. The reaction was maintained at 65°C for 6 hours, and then allowed to cool to room temperature. The resulting polymer was filtered and washed on the funnel with isopropanol, and then immediately slurried in 1000 mL of distilled water. The mixture was stirred for 1/2 hour and then transferred to a blender and blended for five minutes. The polymer slurry was filtered and 1000 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was filtered and the filter cake was slurried two times in 500 mL of methanol each time. Filtration and vacuum drying afforded 30.2 g, 75.9% of the title polymer. TMAEMC co-Sty (58%) crosslinked with 4% divinylbenzene crosslinking co-monomer, TMAEMC co-Sty (33%) crosslinked with 4% divinylbenzene crosslinking co- monomer, and TMAEMC co-Sty (24%) crosslinked with 4% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
12. Preparation of Poly(methacrylamidopropyl-3-
(trimethy1ammonium chloride, co-poly 2, 3, 4, 5. 6-pentafluorostyrene (MAPTAC co-StyF5) To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropyl-3- (trimethylammonium) chloride (MAPTAC) (24.5 mL of a 50% aqueous solution, 13.00 g) , divinylbenzene crosslinking co-monomer (1.00 g) , pentafluorostyrene (6.00 g) , 2- propanol (150 L) , and AIBN (0.50g). The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. After five hours the mixture was very thick so an additional 100 mL of isopropanol was added. The reaction was maintained at 65°C for 24 hours, and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of distilled water. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and 500 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was filtered and the filter cake was slurried two times in 300 mL of methanol each time. Filtration and air drying afforded 7.74 g of the title co-polymer.
MAPTAC co-StyF5 (20%) crosslinked with 5% divinylbenzene crosslinking co-monomer, MAPTAC co-StyF5 (40%) crosslinked with 5% divinylbenzene crosslinking co- monomer, and MAPTAC co-StyF5 (45%) crosslinked with 5% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
13. Preparation of poly(methacrylamidopropyl-3- (trimethylammonium) chloride, co-poly 2-
(trimethylammonium) ethyl methacrylate chloride, co-styrene (MAPTAC co-TMAEMC co- Styj
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropyl-3- (trimethylammonium) chloride (MAPTAC) (10.40 g of a 50% aqueous solution, 5.20 g) , 2-(trimethylammonium) ethyl methacrylate chloride (TMAEMC) (4.86 g of a 70% aqueous solution, 3.40 g) divinylbenzene crosslinking co-monomer (1.00 g) , styrene (10.40 g) , 2-propanol (150 mL) , and AIBN (0.50 g) . The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and 400 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was filtered and the water slurry was repeated. The mixture was filtered and the filter cake was slurried two times in 400 mL of methanol each time. Filtration and air drying afforded 5.39 g of the title co-polymer.
MAPTAC co-TMAEMC (34%) co-Sty (36%) crosslinked with 5% divinylbenzene crosslinking co-monomer, MAPTAC co-TMAEMC (31%) co-Sty (41%) crosslinked with 5% divinylbenzene crosslinking co-monomer, MAPTAC co-TMAEMC (28%) co-Sty (46%) crosslinked with 5% divinylbenzene crosslinking co-monomer, MAPTAC co-TMAEMC (23%) co-Sty (48%) crosslinked with 5% divinylbenzene crosslinking co- monomer, MAPTAC co-TMAEMC (26%) co-Sty (52%) crosslinked with 4% divinylbenzene crosslinking co-monomer, MAPTAC co-TMAEMC (17%) co-Sty (53%) crosslinked with 4% divinylbenzene crosslinking co-monomer, MAPTAC co-TMAEMC (15%) co-Sty (55%) crosslinked with 4% divinylbenzene crosslinking co-monomer, and MAPTAC co-TMAEMC (13%) co- Sty (61.5%) crosslinked with 4% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
14. Preparation of
Poly(trimethylammoniumethylmethacrylate- chloride co-poly(isopropylacrylamide)
(TMAEMAC co-IPA)
The co-monomer isopropylacrylamide (IPA) was first prepared as follows.
Acryloyl chloride (63 L, 70.2 g, 0.775 mol) was dissolved in tetrahydrofuran (200 mL) in a 1 L flask and placed in an ice bath. A solution containing isopropylamine (127.7 mL, 88.67 g, 1.50 mol) was added dropwise, maintaining the temperature at 5-15°C. After addition the solution was stirred for 10 min and the solid isopropylamine hydrochloride was filtered off and discarded. The solvent was removed in vacuo from the mother liquor and the resulting almost colorless oil, which solidified on standing, was used without further purification to prepare the title co-polymer as follows. To a 1000 mL, three-necked flask, round-bottomed flask was added the following: trimethylammoniumethylacrylate chloride (76.5 mL of a 50% aqueous solution, 41.18 g, 0.213 mol), methylene bis acrylamide crosslinking co-monomer (2.40 g) , IPA co- monomer (4.52 g, 0.070 mol), and water (200 mL) . The resulting solution was clear. The reaction mixture was stirred while being degassed with nitrogen. When the solution had been degassed, the catalyst, consisting of potassium persulfate (0.3 g) and potassium metabisulfate (0.3 g) was added. The polymerization initiated after 2 minutes and gelled after 3 minutes.
The next morning the gel was transferred to a blender and 1000 mL of water was added. After blending for a few seconds, the polymer had swelled to take up all of the water. The swollen polymer was blended in several portions with isopropanol several times to dehydrate it. The resulting polymer was filtered and washed on the funnel with isopropanol and vacuum dried to afford 36.8 g of the title co-polymer.
15. Preparation of Poly(methacrylamidopropyltrimethylammonium- chloride) co-polv(vinyl pyridine) (MAPTAC co-VP)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropy1-3- (trimethylammonium) chloride (MAPTAC) (40 mL of a 50% aqueous solution, 21.0 g) , divinyl benzene crosslinking co-monomer (2.25 g) , vinyl pyridine (14.0 g, 0.133 mol), cone, hydrochloric acid (11 mL, 0.133 mol), 2-propanol (300 L) , and AIBN (0.67 g) . The resulting solution was clear. Next, the reaction mixture was heated to 60°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 60°C for 20 hours, and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 1000 mL of distilled water. The mixture was stirred for 1 hour. The polymer slurry was filtered, washed on the funnel with methanol, and then slurried in 600 mL of methanol for one hour. Filtration and air drying afforded 20.4 g of co-polymer.
16. Preparation of
Poly(trimethylammoniumethylmethacrylate- chloride co-poly(p-fluorostyrene)
(TMAEMC co-F1Stv)
To a 500 mL flask was added the following: trimethylammoniumethylmethacrylate chloride (TMAEMC) (11.0 g of a 70% aqueous solution, 7.70 g) , divinylbenzene crosslinking co-monomer (0.50 g) , p- fluorostyrene co-monomer (4.00 g) , 2-propanol (125 mL) and AIBN (0.25 g) . The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. The solution immediately began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 65°C for 6 hours, and then allowed to cool to room temperature. The solvent was removed by decantation and the polymer was immediately slurried in 250 mL of distilled water. The mixture was stirred for 1/2 hour and then decanted. The water slurry was repeated three more times. Finally, the polymer was slurried in 400 mL of methanol. Filtration and vacuum drying afforded 5.42 g, 44.4% of the title co-polymer.
TMAEMC co-F^ty (24%) crosslinked with 4% divinylbenzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of the starting monomers.
17. Preparation of
Poly(methacrylamidopropyltrimethyl ammonium chloride) co-poly(hexafluorobutyl methacrylate) (MAPTAC coF6BMA)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropy1-3- (trimethyla monium) chloride (MAPTAC) (28.5 mL of a 50% aqueous solution, 15.0 g) , divinylbenzene crosslinking co-monomer (1.00 g) , hexafluorobutyl methacrylate (4.00 g) , 2-propanol (150 mL) , and AIBN (0.50 g) . The resulting solution was clear. Next, the reaction mixture was heated to 60°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 60°C for 24 hours, and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of distilled water. The mixture was stirred for 1 hour. The polymer slurry was filtered and the water slurry was repeated one more time. The polymer was then slurried in 500 mL of methanol for one hour and filtered.
The methanol slurry was repeated one more time. Finally the polymer was slurried in 400 mL of isopropanol and stirred overnight. Filtration and air drying afforded
7.52 g of the title co-polymer.
18. Preparation of
Poly(trimethylammoniumethylacrylate chloride) co-poly(hexafluoroisopropy1 acrylate) (TMAEAC co-F6IA)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: trimethylammoniumethylacrylate chloride (30.0 mL of a 50% aqueous solution, 15.0 g) , divinylbenzene crosslinking co-monomer (1.00 g) , F6IPA co-monomer (4.00 g) , AIBN (0.50 g) , and isopropanol (150 mL) . The resulting solution was clear. The reaction mixture was stirred while being degassed with nitrogen and heated to 60°C. After 18 hours the reaction mixture was allowed to cool to room temperature and the solvent was removed by decanting. The residual polymer was slurried in 400 L of water, stirred for one hour and filtered. The water slurry was repeated one more time. Next the polymer was slurried two times in methanol. Finally, the polymer was slurried in 200 mL of isopropanol, stirred for two hours and filtered. Air drying afforded 5.59 g of the title polymer.
19. Preparation of
Poly(methacrylamidopropyltrimethyl ammonium chloride) co-poly(heptadecafluorodecyl methacrylate) (MAPTAC coF17DecMA)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropy1-3- (trimethylammonium) chloride (MAPTAC) (28.5 mL of a 50% aqueous solution, 15.0 g) , divinylbenzene crosslinking co-monomer (1.00 g) , heptadecafluorodecyl methacrylate (4.00 g) , 2-propanol (150 mL) , and AIBN (0.40 g) . The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. After four hours, the reaction mixture had gotten very thick and 100 mL more isopropanol was added. The reaction was maintained at 65°C for 18 hours, and then allowed to cool to room temperature. The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 600 mL of distilled water. The mixture was stirred for 1 hour. The polymer slurry was filtered and the water slurry was repeated one more time. The polymer was then slurried in 500 mL of methanol for one hour and filtered.
Air drying afforded 17.73 g of co-polymer.
20. Preparation of poly(methacrylamidopropy1-3- (trimethylammonium) chloride, co-poly 2- (trimethylammonium) ethyl acrylate chloride, co-poly styrene (MAPTAC co-TMAEAC co-Sty)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropyl-3- (trimethylammonium) chloride (MAPTAC) (10.00 g of a 50% aqueous solution, 5.00 g) , 2-(trimethylammonium) ethyl methacrylate chloride (TMAEAC) ( 6.00 g of a 50% aqueous solution, 3.00 g) divinylbenzene crosslinking co-monomer (1.00 g) , styrene (11.00 g) , 2-propanol (150 mL) , and AIBN (0.25g). The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature. The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/2 hour .
The polymer slurry was allowed to settle and decanted.
200 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was decanted and the water slurry was repeated with 400 mL. The mixture was decanted and the polymer was slurried two times in 200 mL of methanol each time. Filtration and air drying afforded 2.76 g of the title co-polymer.
MAPTAC co-TMAEAC (10%) co-Sty (60%) crosslinked with 5% divinylbenzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of starting monomers.
21. Preparation of poly-2-)trimethylammonium) ethyl acrylate chloride co-poly 2,3,4,5,6- pentafluorostyrene (TMAEAC co-StyF5)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: 2-(trimethylammonium) ethyl acrylate chloride (TMAEAC) (24.0 mL of a 50% aqueous solution, 13.00 g) , divinylbenzene crosslinking co-monomer (1.00 g) , pentafluorostyrene (6.00 g) , 2- propanol (150 mL) , and AIBN (0.50g). The resulting solution was clear. Next, the reaction mixture was heated to 65°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. After two hours the mixture was very thick so an additional 100 mL of isopropanol was added. The reaction was maintained at 65°C for 22 hours, and then allowed to cool to room temperature. The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 400 mL of distilled water. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and 600 mL of distilled water was added and the mixture was stirred for 1/2 hour. The mixture was filtered and the filter cake was slurried in 400 mL of methanol. Filtration and air drying afforded 7.26 g of the title co-polymer.
TMAEAC co-StyF5 (20%) crosslinked with 5% divinylbenzene crosslinking co-monomer was prepared in analogous fashion by varying the ratio of starting monomers.
22. Preparation of 2-(trimethylammonium) ethyl methacrylate chloride, co-poly 2,3,4,5,6- pentafluorostyrene (TMAEMC co-StyF5) To a 1000 mL, three-necked flask, round-bottomed flask was added the following: 2-(trimethylammonium) ethyl methacrylate chloride (TMAEMC) (19.52 of a 70% aqueous solution, 13.66 g) , divinylbenzene crosslinking co-monomer (1.00 g) , pentafluorostyrene (9.18 g) , 2- propanol (150 mL) , and AIBN (0.40g). The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. After 1.5 hours the mixture was very thick so an additional 50 mL of isopropanol was added. The reaction was maintained at 70°C for 5 hours, arid then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 L of distilled water. The mixture was stirred for 1/4 hour. The polymer slurry was filtered and 500 mL of distilled water was added and the mixture was stirred for 1/4 hour. The water slurry was repeated one more time. The mixture was filtered and the filter cake was slurried three times in 300 mL of methanol each time. Filtration and air drying afforded 1.26 g of the title co-polymer.
TMAEMC co-StyF5 (24%) crosslinked with 4% divinylbenzene crosslinking co-monomer and TMAEMC co- StyF5 (39%) crosslinked with 4% divinylbenzene crosslinking co-monomer were prepared in analogous fashion by varying the ratio of starting monomers.
23. Preparation of Poly(ethyleneimine) Polyethyleneimine (120 g of a 50% aqueous solution; Scientific Polymer Products) was dissolved in water (250 mL) . Epichlorohydrin (22.1 L) was added dropwise. The solution was heated to 60°C for 4 h, after which it had gelled. The gel was removed, blended with water (1.5 L) and the solid was filtered off, rinsed three times with water (3 L) and twice with isopropanol (3 L) , and the resulting gel was dried in a vacuum oven to yield 81.2 g of the title polymer.
24. Preparation of Poly(methacrylamidopropyl-3- (trimethylammonium) chloride, co-poly(2- (trimethylammonium) ethylmethacrylate chloride) co-poly 2,3,4,5,6-pentafluorostyrene (MAPTAC co-TMAEMC co-StyF5)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropyl-3- (trimethylammonium) chloride (MAPTAC) (10.00 of a 50% aqueous solution, 5.00 g) , 2-(trimethylammonium) ethyl methacrylate chloride (TMAEMC) (5.71 g of a 70% aqueous solution, 4.00 g) , divinylbenzene crosslinking co-monomer (1.00 g) , pentafluorostyrene (10.00 g) , 2-propanol (150 mL) , and AIBN (0.50g). The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/4 hour. The polymer slurry was filtered and then slurried 3 times in 300 mL of water each time. The last time the polymer slurry was blended for 5 minutes. The mixture was filtered and the filter cake was slurried two times in
300 mL of methanol each time. Filtration and vacuum drying afforded 9.74 g of co-polymer. 25. Preparation of Poly(trimethylammonium) ethyl acrylate chloride, co-poly(2-
(trimethylammonium) ethylmethacrylate chloride) co-styrene (TMAEAC, co-TMAEMC, co-Sty)
To a 1000 L, three-necked flask, round-bottomed flask was added the following: 2-(trimethylammonium) ethyl acrylate chloride (TMAEAC) (6.00 g of a 50% aqueous solution, 3.00 g) , 2-(trimethylammonium) ethyl methacrylate chloride (TMAEMC) (4.29 g of a 70% aqueous solution, 3.00 g) , divinylbenzene crosslinking co-monomer (1.00 g) , styrene (13.00 g) , 2-propanol (150 mL) , and AIBN (0.50g). The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
The resulting polymer was decanted and immediately slurried in 500 mL of methanol. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and 500 mL of distilled water was added. The mixture was then stirred for 1/2 hour and blended for 10 minutes. The mixture was allowed to settle and the water was decanted. The water slurry was repeated two more times and the decantation residue was slurried two times in 400 mL of methanol each time, settling and decanting each time. Vacuum drying afforded 8.03 g of the title co-polymer. 26. Preparation of Poly(methacrylamidopropyl-3- (trimethylammonium) chloride, co-poly(2-
(trimethylammonium) ethylacrylate chloride) co- poly 2,3,4,5,6-pentafluorostyrene (MAPTAC co- TMAEAC CO-StvF5)
To a 1000 mL, three-necked flask, round-bottomed flask was added the following: (methacrylamidopropyl-3- (trimethylammonium) chloride (MAPTAC) (8.00 g of a 50% aqueous solution, 4.00 g) , 2-(trimethylammonium) ethyl acrylate chloride (TMAEMA) (6.00 g of a 50% aqueous solution, 3.00 g) , divinylbenzene crosslinking co-monomer (1.00 g) , pentafluorostyrene (12.00 g) , 2-propanol (150 mL) , and AIBN (0.50g). The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature. The resulting polymer was filtered and washed on the funnel with isopropanol and immediately slurried in 400 mL of methanol. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and then slurried 2 times in 250 mL of water each time. The last time the polymer slurry was blended for 5 minutes. The mixture was filtered and the filter cake was slurried two times in 250 mL of methanol each time. Filtration and vacuum drying afforded 7.80 g of co-polymer.
27. Preparation of Poly(trimethylammonium) ethyl acrylate chloride, co-poly(2-
(trimethylammonium) ethylmethacrylate chloride) co-2,3,4,5,6-pentafluorostyrene (TMAEAC, co- TMAEMC. co-StyF5)
To a 1000 L, three-necked flask, round-bottomed flask was added the following: 2-(trimethylammonium) ethyl acrylate chloride (TMAEAC) (6.00 g of a 50% aqueous solution, 3.00 g) , 2-(trimethylammonium) ethyl methacrylate chloride (TMAEMC) (4.29 g of a 70% aqueous solution, 3.00 g) , divinylbenzene crosslinking co-monomer (1.00 g) , pentafluorostyrene (13.00 g) , 2-propanol (150 mL) , and AIBN (0.50g) . The resulting solution was clear. Next, the reaction mixture was heated to 70°C while being degassed with nitrogen. After a short period of time, the solution began to turn cloudy, indicating that polymerization was proceeding. The reaction was maintained at 70°C for 24 hours, and then allowed to cool to room temperature.
The resulting polymer was decanted and immediately slurried in 400 mL of methanol. The mixture was stirred for 1/2 hour. The polymer slurry was filtered and then slurried two times in 200 mL of water each time. The second time the polymer slurry was blended for 5 minutes. The mixture was filtered and the filter cake was slurried two times in 200 mL of methanol each time. Vacuum drying afforded 6.87 g of co-polymer. Testing of Polymers A. Preparation of Artificial Intestinal Fluid
Sodium carbonate (1.27g) and sodium chloride (1.87g) were dissolved in 400 mL of distilled water. To this solution was added a mixture of purified bile acids, consisting of taurocholic acid (0.138g, 0.24mmol), glycocholic acid (0.292g, 0.60mmol), glycodeoxycholic acid (0.085mmol, O.lδmmol) and glycochenodeoxycholic acid (0.085mmol, 0.18mmol). The pH of the solution was adjusted to 7.20 with acetic acid. This solution was used for the testing of the various polymers. The total bile salt concentration in this solution is 3 millimolar, a concentration approximately equal to that found in normal physiological solutions in the duodenum. Polymers were tested as follows. To a 40mL centrifuge tube was added 0.25g of polymer and 20 mL of the artificial small fluid prepared as described above. The mixture was stirred in a water bath maintained at 37°C for three hours. The mixture was then centrifuged and the supernatant liquid, being slightly cloudy, was filtered. The filtrate was analyzed for total 3-hydroxy steroid content by an enzymatic assay using 3a-ydroxy steroid dehydrogenase, as described below.
Enzymatic Assay for Total Bile Salt Content Four stock solutions were prepared. Solution 1. Tris-HCl buffer, containing 0.133M Tris, 0.666mM EDTA at pH 9.5.
Solution 2. Hydrazine hydrate solution, containing 1M hydrazine hydrate at pH 9.5.
Solution 3. NAD+ solution, containing 7mM NAD+ at pH 7.0.
Solution 4. HSD solution, containing 2units/mL in Tris-HCl buffer (0.03M Tris, ImM EDTA) at pH 7.2.
To a 3 mL cuvette was added 1.5 mL of Solution 1, 1.0 mL of Solution 2, 0.3 mL of Solution 3, 0.1 mL of Solution 4 and 0.1 mL of supernatant/filtrate from a polymer test as described above. The solution was placed in a UV-VIS spectrophotometer and the absorbance (O.D.) of NADH at 340 nm was measured. The bile salt concentration was determined from a calibration curve prepared from dilutions of the artificial intestinal fluid prepared as described above.
All of the polymers previously described were tested in the above manner and all were efficacious in removing bile salts from the artificial intestinal fluid. Use
The polymers according to the invention may be administered orally to a patient in a dosage of about 1 mg/kg/day to about 10 g/kg/day; the particular dosage will depend on the individual patient (e.g., the patient's weight and the extent of bile salt removal required) . The polymer may be administrated either in hydrated or dehydrated form, and may be flavored if necessary to enhance patient acceptability; additional ingredients such as artificial coloring agents may be added as well.
Examples of suitable forms for administration include pills, tablets, capsules, and powders (for sprinkling on food) . The pill, tablet, capsule, or powder can be coated with a substance capable of protecting the composition from the gastric acid in the patient's stomach for a period of time sufficient to allow the composition to pass undisintegrated into the patient's small intestine. The polymer may be administered alone or in combination with a pharmaceutically acceptable carrier substance, e.g., magnesium carbonate, lactose, or a phospholipid with which the polymer can form a micelle.
Other embodiments are within the following claims. What is claimed is:

Claims

1. A method for removing bile salts from a patient by ion exchange comprising administering to said patient a therapeutically effective amount of one or more highly crosslinked polymers characterized by a repeat unit having the formula
or copolymer thereof, where n is an integer; R1 is H or a
O c l~ 8 alkyl group; M is -C-Z-R2 or -Z-R2; Z is O, NR3, S, or (CH2)m; m = 0-10; R3 is H or a C-^Cg alkyl group; and
where p = 0-10, and each R4, R5, and R6, independently, is H, a C-L-CQ alkyl group, or an aryl group, said polymers being non-toxic and stable once ingested.
2. The method of claim 1 wherein said polymer is crosslinked by means of a multifunctional crosslinking co-monomer, said co-monomer being present in an amount from about 1-25% by weight, based upon total monomer weight.
3. The method of claim 2 wherein said crosslinking co-monomer is present in an amount from about 2.5-20% by weight, based upon total monomer weight.
4. The method of claim 1 wherein said polymer further comprises one or more hydrophobic co-monomers.
5. The method of claim 4 wherein said hydrophobic co-monomer comprises styrene and fluorinated derivatives thereof; vinyl naphthalene and fluorinated derivatives thereof; ethyl vinylbenzene and fluorinated derivatives thereof; N-alkyl and N-aryl derivatives of acrylamide and methacrylamide, and fluorinated derivatives thereof; alkyl and aryl acrylates and fluorinated derivatives thereof; and alkyl and aryl methacrylates and fluorinated derivatives thereof.
6. The method of claim 1 wherein said polymer further comprises one or more positively charged co- monomers.
7. The method of claim 6 wherein said positively charged co-monomer comprises vinyl pyridine, dimethylaminomethyl styrene, and vinyl imidazole.
8. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof .
9. The method of claim 8 wherein said polymer further comprises, as a co-monomer, n- butylmethacrylamide.
10. The method of claim 8 wherein said polymer further comprises, as a co-monomer, hexafluorobutylmethacrylate.
11. The method of claim 8 wherein said polymer further comprises, as a co-monomer, heptadecafluorodecylmethacrylate.
12. The method of claim 8 wherein said polymer further comprises, as a co-monomer, styrene or a fluorinated derivative thereof.
13. The method of claim 8 wherein said polymer further comprises, as a co-monomer, 2-vinyl naphthalene.
14. The method of claim 8 wherein said polymer further comprises, as a co-monomer, 4-vinyl imidazole.
15. The method of claim 8 wherein said polymer further comprises, as a co-monomer, vinyl pyridine.
16. The method of claim 8 wherein said polymer further comprises, as a co-monomer, trimethy1ammoniumethylmethacrylate.
17. The method of claim 16 wherein said polymer further comprises, as a co-monomer, styrene or a fluorinated derivative thereof.
18. The method of claim 8 wherein said polymer further comprises, as a co-monomer, trimethylammoniumethylacrylate.
19. The method of claim 18 wherein said polymer further comprises, as a co-monomer, styrene or a fluorinated derivative thereof.
20. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof.
21. The method of claim 20 wherein said polymer further comprises, as a co-monomer, isopropylacrylamide.
22. The method of claim 20 wherein said polymer further comprises, as a co-monomer, styrene or a fluorinated derivative thereof.
23. The method of claim 20 wherein said polymer further comprises, as a co-monomer hexafluoroisopropylacrylate.
24. The method of claim 20 wherein said polymer further comprises, as a co-monomer, trimethylammoniumethylmethacrylate.
25. The method of claim 24 wherein said polymer further comprises, as a co-monomer, styrene or a fluorinated derivative thereof.
26. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof.
27. The method of claim 26 wherein said polymer further comprises, as a co-monomer, styrene or a fluorinated derivative thereof.
28. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof.
29. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof.
30. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof.
31. The method of claim 30 wherein said polymer further comprises, as a co-monomer, ethyl vinylbenzene.
32. The method of claim 1 wherein said polymer is characterized by a repeat unit having the formula
or copolymer thereof.
33. The method of claim of 1 wherein said polymer further comprises one or more exchangeable counterions.
34. The method of claim 33 wherein at least one of said counterions comprises Cl~, Br", CH3OS03", HS04~, S04 2'
, HC03~, C03 ", acetate, lactate, succinate, propionate, butyrate, ascorbate, citrate, maleate, folate, an amino acid derivative, a nucleotide, a lipid, or a phospholipid.
35. A therapeutic composition effective for removing bile salts by ion exchange comprising a therapeutic amount of a highly crosslinked polymer characterized by a repeat unit having the formula
or copolymer thereof, where n is an integer; R1 is H or
O ^-C8 alkyl group; M is -C-Z-R2 or -Z-R2; Z is O, NR3, S,
H, a C1-C8 alkyl group, or an aryl group, said polymer being non-toxic and stable once ingested.
36. A highly crosslinked polymer composition comprising a polymer characterized by a repeat unit having the formula
where R1 is H or methyl, Q is -NH-(CH2)3- or -0-(CH2)2 and n is an integer, and at least one additional co-monomer selected from the group consisting essentially of vinylnaphthalene, vinylimidazole, fluorinated derivatives of styrene, and fluorinated alkyl methacrylates.
37. The composition of claim 36 wherein R1 is methyl and Q is -NH-(CH2)3-.
38. The composition of claim 37 further comprising, as a co-monomer, trimethylammoniumethylacrylate or trimethylammoniumethylmethacrylate.
39. The composition of claim 36 wherein Q is -0-(CH2)2.
40. The composition of claim 36 wherein said fluorinated derivative of styrene comprises p- fluorostyrene and pentafluorostyrene.
41. The composition of claim 36 wherein said fluorinated alkyl methacrylate comprises hexafluorobutyl methacrylate and heptadecafluorodecyl methacrylate.
42. A highly crosslinked polymer composition comprising a polymer characterized by a repeat unit having the formula
where R1 is H or methyl, Q is -NH-(CH2)3- or -0-(CH2)2 and n is an integer, and, as additional co-monomers, (a) styrene and (b) trimethylammoniumethylacrylate or trimethylammoniumethylmethacrylate when R1 is methyl and Q is -NH-(CH2)3-, and methylacrylamidopropyltrimethylammonium when R1 is H or methyl and Q is -0-(CH2)2.
43. A method of synthesizing a highly crosslinked polymer having hydrophilic and hydrophobic units comprising reacting hydrophilic and hydrophobic monomers in the presence of an alcoholic solvent.
EP94919283A 1993-06-02 1994-05-27 Compositions and process for removing bile salts Withdrawn EP0706399A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7156493A 1993-06-02 1993-06-02
US71564 1993-06-02
PCT/US1994/006042 WO1994027620A1 (en) 1993-06-02 1994-05-27 Compositions and process for removing bile salts

Publications (2)

Publication Number Publication Date
EP0706399A1 true EP0706399A1 (en) 1996-04-17
EP0706399A4 EP0706399A4 (en) 1998-08-12

Family

ID=22102137

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94919283A Withdrawn EP0706399A4 (en) 1993-06-02 1994-05-27 Compositions and process for removing bile salts

Country Status (4)

Country Link
EP (1) EP0706399A4 (en)
JP (1) JPH09500368A (en)
AU (1) AU7047994A (en)
WO (1) WO1994027620A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5487888A (en) * 1993-05-20 1996-01-30 Geltex, Inc. Iron-binding polymers for oral administration
US6129910A (en) * 1993-06-02 2000-10-10 Geltex Pharmaceuticals, Inc. Water-insoluble noncrosslinked bile acid sequestrants
US5703188A (en) * 1993-06-02 1997-12-30 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5624963A (en) * 1993-06-02 1997-04-29 Geltex Pharmaceuticals, Inc. Process for removing bile salts from a patient and compositions therefor
US5929184A (en) * 1993-06-02 1999-07-27 Geltex Pharmaceuticals, Inc. Hydrophilic nonamine-containing and amine-containing copolymers and their use as bile acid sequestrants
US5900475A (en) * 1994-06-10 1999-05-04 Geltex Pharmaceuticals, Inc. Hydrophobic sequestrant for cholesterol depletion
US5618530A (en) * 1994-06-10 1997-04-08 Geltex Pharmaceuticals, Inc. Hydrophobic amine polymer sequestrant and method of cholesterol depletion
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
US5496545A (en) * 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
US5667775A (en) 1993-08-11 1997-09-16 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
TW474813B (en) 1994-06-10 2002-02-01 Geltex Pharma Inc Alkylated composition for removing bile salts from a patient
US6203785B1 (en) 1996-12-30 2001-03-20 Geltex Pharmaceuticals, Inc. Poly(diallylamine)-based bile acid sequestrants
FR2757866B1 (en) * 1996-12-30 2004-12-17 Catalyse POLYMERS COMPRISING QUATERNARY AMMONIUM GROUPS, THEIR USE FOR THE MANUFACTURE OF AN ANTIBACTERIAL PROPERTY MATERIAL AND THEIR PREPARATION METHODS
US5925379A (en) * 1997-03-27 1999-07-20 Geltex Pharmaceuticals, Inc. Interpenetrating polymer networks for sequestration of bile acids
US6423754B1 (en) 1997-06-18 2002-07-23 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with polyallylamine polymers
US6726905B1 (en) 1997-11-05 2004-04-27 Genzyme Corporation Poly (diallylamines)-based phosphate binders
US6190649B1 (en) 1999-04-23 2001-02-20 Geltex Pharmaceuticals, Inc. Polyether-based bile acid sequestrants
EP1196181A1 (en) * 1999-07-14 2002-04-17 Geltex Pharmaceuticals, Inc. Fat-binding polymers, optionally combined with lipase inhibitors
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CN1509180A (en) * 2001-04-18 2004-06-30 ԭ���ø� Method for treating syndrome X with aliphatic polyamines
WO2005092349A1 (en) 2004-03-26 2005-10-06 Mitsubishi Pharma Corporation Insulin resistance improving agent
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
EP1951266A2 (en) 2005-09-02 2008-08-06 Genzyme Corporation Method for removing phosphate and polymer used therefore
CN101272762B (en) 2005-09-15 2013-02-06 基酶有限公司 Sachet formulation for amine polymers
DE102006007564A1 (en) * 2006-02-16 2007-08-30 Röhm Gmbh Nanoscale superparamagnetic poly (meth) acrylate polymers
WO2007145308A1 (en) 2006-06-16 2007-12-21 Mitsubishi Tanabe Pharma Corporation Agent for prevention and/or treatment of glomerulopathy
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
MA41202A (en) 2014-12-18 2017-10-24 Genzyme Corp CROSS-LINKED POLYDIALLYMINE COPOLYMERS FOR THE TREATMENT OF TYPE 2 DIABETES

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
EP0373852A2 (en) * 1988-12-13 1990-06-20 Smith Kline & French Laboratories Limited Compounds
JPH059234A (en) * 1991-06-28 1993-01-19 Chuichi Hirayama Pyrogen-adsorbing substance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3953406A (en) * 1973-01-26 1976-04-27 California Institute Of Technology Water-insoluble, swellable polyurethanes
JPS57142920A (en) * 1981-03-02 1982-09-03 Mitsubishi Petrochem Co Ltd Cholesterol depressant
WO1983002392A1 (en) * 1982-01-18 1983-07-21 Kihara, Kunio Cholesterol lowering drug
ES2006782A6 (en) * 1987-07-15 1989-05-16 Garcia Alonso Julio Anionic ion exchange resin prepn.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3308020A (en) * 1961-09-22 1967-03-07 Merck & Co Inc Compositions and method for binding bile acids in vivo including hypocholesteremics
EP0373852A2 (en) * 1988-12-13 1990-06-20 Smith Kline & French Laboratories Limited Compounds
JPH059234A (en) * 1991-06-28 1993-01-19 Chuichi Hirayama Pyrogen-adsorbing substance

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 114, no. 12, 25 March 1991 Columbus, Ohio, US; abstract no. 109016, XP002065385 & ES 2 006 782 A (GARCIA ALONSO) 16 May 1989 *
PATENT ABSTRACTS OF JAPAN vol. 017, no. 274 (C-1064), 27 May 1993 & JP 05 009234 A (CHUICHI HIRAYAMA;OTHERS: 03), 19 January 1993, *
See also references of WO9427620A1 *

Also Published As

Publication number Publication date
AU7047994A (en) 1994-12-20
WO1994027620A1 (en) 1994-12-08
EP0706399A4 (en) 1998-08-12
JPH09500368A (en) 1997-01-14

Similar Documents

Publication Publication Date Title
US6060517A (en) Process for removing bile salts from a patient and compositions therefor
WO1994027620A1 (en) Compositions and process for removing bile salts
EP0764177B1 (en) Crosslinked polymer containing composition for removing bile salts from a patient
KR100271693B1 (en) Process for removing bile salts from a patient and alkylated composition used for the process
AU735260C (en) Polyallylamine polymers for treating hypercholesterolemia
EP1416942B1 (en) Amine polymers for treating gout and binding uric acid

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19951201

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

R17P Request for examination filed (corrected)

Effective date: 19960130

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20000105

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20010903